AssetMark Inc’s Inovio Pharmaceuticals INO Stock Holding History

AssetMark Inc’s Portfolio INO Stock Details INO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-21	Closed	-$2K	–	482
2014 Q4	$2K	Buy	+21	New	+$2.57K	﹤0.01%	461

Other funds holding INO

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

AssetMark Inc's INO Position: Q1 2015 in Review

AssetMark Inc sold out of Inovio Pharmaceuticals (INO) in Q1 2015, closing a stake of 21 shares — an estimated $2K sold.

AssetMark Inc first reported a position in INO in Q4 2014 and held it in 1 quarter. The position peaked at $2K in Q4 2014. 98 funds tracked by Wall St. Rank hold INO as of Q1 2015.

AssetMark Inc reported no remaining Inovio Pharmaceuticals position as of Q1 2015 after selling out during the quarter.
AssetMark Inc sold 21 Inovio Pharmaceuticals shares in Q1 2015, an estimated $2K.
AssetMark Inc first reported a position in Inovio Pharmaceuticals in Q4 2014 and held it in 1 quarter.
AssetMark Inc's Inovio Pharmaceuticals position peaked at $2K in Q4 2014.
98 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q1 2015.

Based on AssetMark Inc's 13F filing for Q1 2015, filed 12 May 2015.